Just Released: "South Africa Pharmaceuticals & Healthcare Report Q2 2014"
South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market - boasting the largest medicines market on the continent and poised for high single-digit growth over the next decade. This quarter highlighted issues surrounding intellectual property protection, in which the Innovative Pharmaceutical Association SA (IPASA) was implicated in the leakage of draft response campaigning against proposed changes to South Africa's intellectual property, and the impact of local currency depreciation - positive for local drugmakers...
View full press release